This is the authors' abstract. We don't add key points for this paper.
Our purpose was to prospectively assess the distribution of NETPET scores in well-differentiated (WD) grade 2 and 3 gastroenteropancreatic (GEP) neuroendocrine tumors (NETs) and to determine the impact of the NETPET score on clinical management.
Answers are grounded in this paper and cite their sources.
No takes yet. Share an insight, caveat, or question.
Metser et al. (2024) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: